Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
4.020
+0.060 (1.52%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Phathom Pharmaceuticals Market Cap
Phathom Pharmaceuticals has a market cap or net worth of $274.88 million as of April 24, 2025. Its market cap has decreased by -56.47% in one year.
Market Cap
274.88M
Enterprise Value
532.56M
1-Year Change
-56.47%
Ranking
Category
Stock Price
$4.02
Market Cap Chart
Since October 25, 2019, Phathom Pharmaceuticals's market cap has decreased from $527.13M to $274.88M, a decrease of -47.85%. That is a compound annual growth rate of -11.17%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.12B |
| UnitedHealth Group | 388.83B |
| Johnson & Johnson | 380.15B |
| AbbVie | 307.41B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.46B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |